Search results for "Amyotrophic lateral sclerosis"

showing 10 items of 228 documents

Corticobulbar tract involvement in amyotrophic lateral sclerosis. A transcranial magnetic stimulation study

1998

We investigated corticobulbar tract function by recording from the tongue and orofacial muscles and using transcranial magnetic stimulation (TMS) in 30 patients with amyotrophic lateral sclerosis (ALS) in order to improve the diagnostic yield in the detection of subclinical upper motor neuron (UMN) dysfunction. A UMN lesion was assumed when the peripheral conduction time and amplitude of the M-wave were within normal range and either the response to cortical stimulation was absent, or the central conduction time was delayed (> mean + 2.5 SD). Only two patients showed clinical evidence of UMN involvement in the cranial nerves, while TMS demonstrated corticobulbar tract dysfunction in the oro…

Adultmedicine.medical_treatmentPyramidal TractsFacial MusclesCentral nervous system diseaseTongueTonguePhysical StimulationmedicineHumansAmyotrophic lateral sclerosisAgedSubclinical infectionMouthbusiness.industryUpper motor neuronAmyotrophic Lateral SclerosisCranial nervesAnatomyMiddle Agedmedicine.diseaseTranscranial Magnetic StimulationTranscranial magnetic stimulationmedicine.anatomical_structureCorticobulbar tractNeurology (clinical)businessBrain
researchProduct

Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

2019

Age is the main risk factor for a number of human diseases, including neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, which increasing numbers of elderly individuals suffer. These pathological conditions are characterized by progressive loss of neuron cells, compromised motor or cognitive functions, and accumulation of abnormally aggregated proteins. Mitochondrial dysfunction is one of the main features of the aging process, particularly in organs requiring a high-energy source such as the heart, muscles, brain, or liver. Neurons rely almost exclusively on the mitochondria, which produce the energy required for most of the cel…

AgingAntioxidantMitochondrial Diseasesmedicine.medical_treatmentneurodegeneration oxidative stress mitochondiaDiseaseReview ArticleMitochondrionBiologymedicine.disease_causeBiochemistryAntioxidantsAlzheimer DiseasemedicineHumansAmyotrophic lateral sclerosislcsh:QH573-671lcsh:CytologyNeurodegenerationParkinson DiseaseCell BiologyGeneral Medicinemedicine.diseaseMitochondriaOxidative Stressmedicine.anatomical_structureSynaptic plasticityNeuronNeuroscienceOxidative stress
researchProduct

CHARACTERIZATION OF MOLECULAR ISOFORMS AND ROLE OF THE SURVIVAL MOTOR NEURON (SMN) IN MOTOR NEURONS DISEASES.

2014

La sclerosi Laterale Amiotrofica (SLA) e l'Atrofia Muscolare Spinale (SMA) sono malattie neurodegenerative caratterizzate dalla perdita progressiva dei motoneuroni. La SMA è generalmente causata da delezione in omozigosi o mutazione del gene SMN, che codifica per una proteina ubiquitaria e multifunzionale, altamente espressa nel midollo spinale. La SLA è una malattia che può essere familiare o sporadica.Il 20% dei casi familiari è causato da una mutazione dominante nel gene SOD1. Inoltre ci sono altri geni coinvolti in questa malattia, tra cui FUS e TDP43. Lo scopo principale della tesi è quello di studiare il gene, le isoforme, la localizzazione subcellulare ed i partners molecolari di SMN…

Amyotrophic Lateral Sclerosis (ALS) SMN FUS TDP-43.Sclerosi laterale amiotrofica (SLA) SMNFUSTDP-43.Settore BIO/09 - Fisiologia
researchProduct

Tumors preceding ALS onset and ALS: results from a case-control study.

2009

Amyotrophic Lateral Sclerosis Cancer Case-comntrol studySettore MED/26 - Neurologia
researchProduct

The ALS-FTLD continuum: clinical, genetic and neuropsychological aspects

Amyotrophic lateral sclerosis frontotemporal lobar degeneration
researchProduct

Alexithymia, burden and resilience in ALS’ caregivers

2017

Living with a progressively disease such as Amyotrophic lateral sclerosis (ALS) has a strong impact on the people affected and on their relatives, who have to tackle the demanding duties of caring for and assisting them (Tramonti et al., 2014). Many factors modulate the levels of burden in ALS’ caregivers: disease related factors, personality related factors, enviromental factors. Dennison et al (2001) showed that alexithymia could to contribute to increasing distress in ALS’ caregivers, but there are very few studies on this. Other studies supporting the role of resilience such as protective factor (Ripamonti, 2015). The aim of the study is to assess the relationship between alexithymia, r…

Amyotrophic lateral sclerosisalexithymiaasl'caregiversresilienceburdenalexithymiaasl'caregiversAmyotrophic lateral sclerosisresilienceburden
researchProduct

Non-invasive management of an acute chest infection for a patient with ALS.

2003

We describe a man diagnosed with non-bulbar amyotrophic lateral sclerosis (ALS) who uses 24-h non-invasive ventilator at home, and assisted cough through the use of the mechanical insufflation-exsufflation (MAC) device (CoughAssist, J.H. Emerson). This was essential for the removal of bronchial secretions in order to provide successful non-invasive management (and indeed less suffering for the patient) during an acute respiratory tract infection with hypoxemia and failure of manually assisted cough.

Artificial ventilationMalemedicine.medical_specialtyRespiratory Therapymedicine.medical_treatmentHypoxemiaIntensive caremedicineHumansAmyotrophic lateral sclerosisIntensive care medicineHypoxiaAcute respiratory tract infectionEmergency TreatmentRespiratory Tract InfectionsAgedRespiratory tract infectionsbusiness.industryRespiratory diseaseAmyotrophic Lateral Sclerosismedicine.diseaseRespiration Artificialrespiratory tract diseasesNeurologyAcute DiseaseNeurology (clinical)Exsufflationmedicine.symptombusinessJournal of the neurological sciences
researchProduct

Outcome and attitudes toward home tracheostomy ventilation of consecutive patients: a 10-year experience.

2008

Summary Objectives To describe survival, predictors of long-term outcome and attitudes in patients treated at home by tracheostomy-intermittent positive-pressure ventilation (TIPPV) for respiratory failure during a 10-year period (1995–2004). Methods Seventy-seven consecutive patients were treated by TIPPV at home. Patients were divided into three groups: neuromuscular, pulmonary, and non-pulmonary patients. Effects of TIPPV on survival, factors influencing outcome after TIPPV, and attitudes of patients and caregivers regarding mechanical ventilation were studied. Results Forty-one patients (53%) were neuromuscular, 19 (25%) were affected by pulmonary diseases, and 17 (22%) by non-pulmonary…

Artificial ventilationPulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtySurvivalHome Nursingmedicine.medical_treatmentRespiratory failureIntermittent Positive-Pressure VentilationPulmonary Disease Chronic ObstructiveTracheotomyTracheostomyInternal medicinemedicineCOPDHumansProspective StudiesProspective cohort studySurvival rateAgedMechanical ventilationAged 80 and overCOPDbusiness.industryTracheostomy mechanical ventilationRespiratory diseaseAmyotrophic Lateral SclerosisNeuromuscular DiseasesMiddle Agedmedicine.diseaseRespiration ArtificialSurgerySurvival RateCaregiversRespiratory failureFemaleALSbusinessRespiratory InsufficiencyAttitude to HealthRespiratory medicine
researchProduct

Hsp70 and Its Molecular Role in Nervous System Diseases

2011

Heat shock proteins (HSPs) are induced in response to many injuries including stroke, neurodegenerative disease, epilepsy, and trauma. The overexpression of one HSP in particular, Hsp70, serves a protective role in several different models of nervous system injury, but has also been linked to a deleterious role in some diseases. Hsp70 functions as a chaperone and protects neurons from protein aggregation and toxicity (Parkinson disease, Alzheimer disease, polyglutamine diseases, and amyotrophic lateral sclerosis), protects cells from apoptosis (Parkinson disease), is a stress marker (temporal lobe epilepsy), protects cells from inflammation (cerebral ischemic injury), has an adjuvant role i…

Autoimmune diseasebusiness.industryMultiple sclerosisNeurodegenerationReview ArticleDiseaseHsp70 nervous system neurodegenerative diseasesmedicine.diseaseBiochemistrylcsh:BiochemistryCellular stress responseHeat shock proteinImmunologymedicinelcsh:QD415-436Alzheimer's diseaseAmyotrophic lateral sclerosisbusinessBiochemistry Research International
researchProduct

The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS

2021

Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disease of the motor system. It is characterized by the degeneration of both upper and lower motor neurons, which leads to muscle weakness and paralysis. ALS is incurable and has a bleak prognosis, with median survival of 3–5 years after the initial symptomatology. In ALS, motor neurons gradually degenerate and die. Many features of mitochondrial dysfunction are manifested in neurodegenerative diseases, including ALS. Mitochondria have shown to be an early target in ALS pathophysiology and contribute to disease progression. Disruption of their axonal transport, excessive generation of reactive oxygen species, disruptio…

BioenergeticsQH301-705.5Calcium bufferingredox statusReviewMitochondrionmedicine.disease_causebioenergeticsCatalysisInorganic ChemistryMitophagymedicineAnimalsHumansoxidative stressPhysical and Theoretical ChemistryAmyotrophic lateral sclerosisBiology (General)Molecular BiologyQD1-999SpectroscopyMotor Neuronschemistry.chemical_classificationReactive oxygen speciesbusiness.industryAmyotrophic Lateral SclerosisOrganic ChemistryGeneral Medicinemedicine.diseaseComputer Science ApplicationsmitochondriaChemistrychemistryAxoplasmic transportALSEnergy MetabolismbusinessOxidation-ReductionNeuroscienceOxidative stressInternational Journal of Molecular Sciences
researchProduct